Therapeutic hypothermia for acute liver failure
- 1 July 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 37 (upplement), S258-S264
- https://doi.org/10.1097/ccm.0b013e3181aa5fb8
Abstract
Cerebral edema is a potentially life-threatening complication of acute liver failure, the syndrome of abrupt loss of liver function in a patient with a previously healthy liver. Although the prevalence of cerebral edema appears to be decreasing, patients with rapidly progressive (hyperacute) liver failure, such as after acetaminophen overdose, remain at highest risk. In severe cases of cerebral edema, intracranial hypertension develops and leads to brain death after brainstem herniation or to anoxic brain injury and permanent neurologic impairment. Intracranial hypertension in patients with acute liver failure often can be temporarily controlled by manipulating body position, increasing the degree of sedation, and increasing blood osmolarity through pharmacologic means. However, these maneuvers often postpone, but do not eliminate, the risk of brainstem herniation unless orthotopic liver transplantation or spontaneous liver regeneration follows in short order. To buy time, the induction of therapeutic hypothermia (core temperature 32 degrees C-35 degrees C) has been shown to effectively bridge patients to transplant. Similar to the experience in patients with cerebral edema after other neurologic insults, hypothermia reduces cerebral edema and intracranial hypertension in patients with acute liver failure by decreasing splanchnic ammonia production, restoring normal regulation of cerebral hemodynamics, and lowering oxidative metabolism within the brain. Hypothermia may also ameliorate the degree of liver injury. Hypothermia has not been adequately studied for its safety and theoretically may increase the risk of infection, cardiac dysrhythmias, and bleeding, all complications independently associated with acute liver failure. Therefore, although an ample body of experimental and human data provides a rationale for the use of therapeutic hypothermia in patients with acute liver failure, multicenter, randomized, controlled clinical trials are needed to confirm that hypothermia secures brain viability and improves survival without causing harm.This publication has 58 references indexed in Scilit:
- Mild hypothermia does not affect liver regeneration after partial hepatectomy in miceLiver International, 2009
- Mild Hypothermia Attenuates Liver Injury and Improves Survival in Mice With Acetaminophen ToxicityGastroenterology, 2007
- The pathophysiology of brain edema in acute liver failureNeurochemistry International, 2005
- Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flowJournal of Hepatology, 2004
- The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failureHepatology, 2004
- Oxidative and nitrosative stress in ammonia neurotoxicityHepatology, 2003
- Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermiaHepatology, 2001
- Reye's Syndrome in the United States from 1981 through 1997The New England Journal of Medicine, 1999
- Indomethacin normalizes intracranial pressure in acute liver failure: A twenty-three-year-old woman treated with indomethacinHepatology, 1997
- Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: A retrospective studyHepatology, 1994